false
OasisLMS
Catalog
Medical Center Occupational Health Basics
Tuberculosis
Tuberculosis
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the first video, Dr. Wendy Tanasi provides an overview of tuberculosis (TB), discussing its history, epidemiology, and current challenges. She highlights important milestones in TB research and emphasizes the global impact of the disease, with approximately 1.5 million deaths annually. Dr. Tanasi also discusses the demographics of TB, including its prevalence among foreign-born individuals and higher risk among populations with HIV/AIDS. The video concludes with a discussion on TB testing policies and the supply chain for diagnostic tools.<br /><br />In the second video, the speaker focuses on the issue of medical waste in the healthcare industry and the need to reduce it. They stress the importance of being environmentally responsible and provide arguments to address this issue with leadership. The video also delves into the history and evolution of TB testing guidelines, particularly the shift from skin tests to interferon gamma release assays (IGRAs). The advantages of IGRAs over skin tests, such as accuracy and ease of use, are highlighted. The use of IGRAs in post-exposure and annual TB testing is discussed. Additionally, the video introduces a shorter treatment regimen, 3-HP, for latent TB infection, which is recommended due to its higher compliance rate, lower risk of hepatotoxicity, and equal efficacy compared to previous regimens. Healthcare professionals are encouraged to educate themselves and others about TB and consider implementing the 3-HP regimen. No credits were provided for this video.
Keywords
tuberculosis
history
epidemiology
challenges
HIV/AIDS
TB testing policies
medical waste
IGRAs
3-HP
×
Please select your language
1
English